|
Atomistry » Magnesium » PDB 2a6h-2alz » 2a7q | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Magnesium » PDB 2a6h-2alz » 2a7q » |
Magnesium in PDB 2a7q: Crystal Structure of Human Dck Complexed with Clofarabine and AdpEnzymatic activity of Crystal Structure of Human Dck Complexed with Clofarabine and Adp
All present enzymatic activity of Crystal Structure of Human Dck Complexed with Clofarabine and Adp:
2.7.1.74; Protein crystallography data
The structure of Crystal Structure of Human Dck Complexed with Clofarabine and Adp, PDB code: 2a7q
was solved by
Y.Zhang,
J.A.Secrist Iii,
S.E.Ealick,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 2a7q:
The structure of Crystal Structure of Human Dck Complexed with Clofarabine and Adp also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Human Dck Complexed with Clofarabine and Adp
(pdb code 2a7q). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Crystal Structure of Human Dck Complexed with Clofarabine and Adp, PDB code: 2a7q: Magnesium binding site 1 out of 1 in 2a7qGo back to![]() ![]()
Magnesium binding site 1 out
of 1 in the Crystal Structure of Human Dck Complexed with Clofarabine and Adp
![]() Mono view ![]() Stereo pair view
Reference:
Y.Zhang,
J.A.Secrist,
S.E.Ealick.
The Structure of Human Deoxycytidine Kinase in Complex with Clofarabine Reveals Key Interactions For Prodrug Activation. Acta Crystallogr.,Sect.D V. 62 133 2006.
Page generated: Tue Aug 13 21:27:04 2024
ISSN: ISSN 0907-4449 PubMed: 16421443 DOI: 10.1107/S0907444905034293 |
Last articlesMg in 1XS2Mg in 1XRJ Mg in 1XRB Mg in 1XRA Mg in 1XPU Mg in 1XR1 Mg in 1XQA Mg in 1XPY Mg in 1XPR Mg in 1XPO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |